跳至主要内容
临床试验/NCT07171281
NCT07171281招募中不适用

Precise Eating Time to Improve Glycemic Control and Cardiometabolic Health in Prediabetes and Diabetes: the GLYCOTIME Trial

German Institute of Human Nutrition2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年9月19日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
30
试验地点
2
主要终点
Mean 24-hour glucose

研究概览

简要总结

The objective of this study is to investigate the impact of hypocaloric time-restricted eating (TRE) at different day times (early versus late TRE) on glucose metabolism and other cardiometabolic parameters in individuals with overweight and with normal, or impaired glucose metabolism (prediabetes and type 2 diabetes). In addition, the study aims to elucidate the molecular mechanisms underlying these effects.

详细描述

This dietary intervention study will follow a crossover design. During the intervention phases, participants will restrict their dietary intake to a defined eating window of 8 hours - predominantly in the morning (early TRE) or predominantly in the afternoon (late TRE) - in conjunction with a moderate caloric restriction for five weeks. A 10-12-week washout phase will separate the intervention periods.

Overweight and obese individuals with healthy glucose metabolism, prediabetes, or non-insulin-treated type 2 diabetes will be recruited for the study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Overweight or obesity (BMI 25-40 kg/m²)
  • Healthy glucose metabolism (fasting glucose <100 mg/dl and glucose after 2 hours OGTT <140 mg/dl)
  • OR impaired glucose metabolism (fasting glucose 100-125 mg/dl and/or glucose after 2 hours OGTT 140-199 mg/dl and/or HbA1c 5.7-6.4%)
  • OR type 2 diabetes (according to existing medical diagnosis or fasting glucose >126 mg/dl and/or glucose after 2 hours OGTT >200 mg/dl and/or HbA1c ≥6.5%)
  • Daily eating window ≥12 hours

排除标准

  • Weight changes > 5% within past 3 months
  • Shift work
  • Traveling across more than one time zone within one month prior to the study
  • Pregnancy and breastfeeding
  • Eating disorders, food intolerance/allergy to ingredients in the diet product, vegan diet, practicing time-restricted eating
  • Severe chronic illnesses or other conditions that are incompatible with the planned intervention and examination program (e.g. type 1 diabetes, recent cardiovascular event, malabsorption, cancer in the last two years, etc.)
  • Treatment with insulin, sulfonylureas, and GLP-1 receptor agonists, steroid use (oral, cutaneous, or parenteral), regular intake of melatonin, anticoagulation treatment that cannot be paused
  • Extreme early and extreme late chronotypes

结局指标

主要结局

Mean 24-hour glucose

时间窗: 5 weeks

Mean 24-hour glucose assessed by continuous glucose monitoring (CGM)

次要结局

  • Waist and hip circumference(5 weeks)
  • Body composition(5 weeks)
  • Glycemic variability(5 weeks)
  • Glucose levels(5 weeks)
  • Insulin levels(5 weeks)
  • Glucagon levels(5 weeks)
  • Insulin resistance(5 weeks)
  • Insulin secretion(5 weeks)
  • Body weight(5 weeks)
  • Body Mass Index (BMI)(5 weeks)
  • Fasting cholesterol(5 weeks)
  • Fasting triglycerides(5 weeks)
  • Blood pressure(5 weeks)
  • Resting energy expenditure(5 weeks)
  • Gene expresssion in adipose tissue(5 weeks)
  • Inflammatory markers in blood and adipose tissue(5 weeks)
  • Subjective satiety and hunger sensation(5 weeks)
  • Concentration of satiety and hunger regulating hormones(5 weeks)
  • Species and strain-level microbiome changes(5 weeks)
  • Levels of microbiome-derived metabolites(5 weeks)
  • Sleep quality(5 weeks)
  • Sleep and wake timing(5 weeks)
  • Internal circadian phase(Screening visit (week 0))
  • Glucagon-like peptide-1 levels(5 weeks)
  • Gastric inhibitory polypeptide(5 weeks)
  • Gene expresssion in peripheral mononuclear blood cells (PBMCs)(5 weeks)
  • Malondialdehyde(5 weeks)
  • 3-nitrotyrosine(5 weeks)
  • Protein carbonyls(5 weeks)
  • 36-item Short Form Health Survey (SF-36) to measure health-related quality-of-life(5 weeks)
  • Satisfaction with the intervention(5 weeks)
  • Decision behavior(5 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Olga Ramich (formerly Pivovarova)

Head of Department Molecular Metabolism and Precision Nutrition

German Institute of Human Nutrition

研究点 (2)

Loading locations...

相似试验